x

Search for a clinical trial

* (*) mandatory field

An Open-Label Study for Previously Treated Ataluren (PTC124®) Patients with Nonsense Mutation Dystrophinopathy (phase III) - UK

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • Pr Kate BUSHBY
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine
  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Trust
  • Central Parkway
  • NEWCASTLE UPON TYNE NE1 3BZ
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)191 241 8640
  • Fax  : -
  • Website
  • Contact secretary  :
  • Investigator of clinical trial

  • Dr Michela GUGLIERI
  • John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine
  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Trust
  • Central Parkway
  • NEWCASTLE UPON TYNE NE1 3BZ
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)191 241 8640
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: June 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.